Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

February 3, 2022

Study Completion Date

March 8, 2022

Conditions
PTSD
Interventions
DEVICE

Therapist Guided Prolonged Exposure with BioWare Device

"Experimental: Intelligent Biometrics - Prolonged Exposure (therapist guided). In the therapist guided group, Study Therapists will use actionable data during in vivo exposures (IVEs) (galvanic skin response \[GSR\], heart rate \[HR\], and subjective units of distress \[SUDS\]) to modify the assignments in real-time.~All participants receive at least 10 sessions of prolonged exposure therapy for posttraumatic stress disorder."

DEVICE

Record Only Prolonged Exposure with BioWare Device

"In the record-only group, passive data collection will be utilized to collect and store biometric and behavioral data for future offline analyses to investigate predictors of outcome.~All participants receive at least 10 sessions of prolonged exposure therapy for posttraumatic stress disorder."

Trial Locations (1)

29401

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

Zeriscope

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT04471207 - Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial | Biotech Hunter | Biotech Hunter